
224.72 Delayed Data As of Mar 27 | ![]() Today’s Change | 118.18 Today|||52-Week Range 280.62 | +2.17% Year-to-Date |
Prelude (PRLD) Collaborates With BeiGene for Oncology Candidate Mar 16 / Zacks.com - Paid Partner Content |
Previous close | 219.71 |
Today’s open | 219.33 |
Day’s range | 219.00 - 224.79 |
Volume | 181,107 |
Average volume (3 months) | 253,003 |
Market cap | $21.0B |
Earnings growth (last year) | -27.55% |
Earnings growth (this year) | +31.68% |
Earnings growth (next 5 years) | -18.89% |
Revenue growth (last year) | +20.37% |
P/E ratio | NM |
Price/Sales | 16.02 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
TEVATeva Pharmaceutical | +0.29 | +3.44% |
BBIOBridgeBio Pharma Inc | -0.58 | -3.89% |
IDRSFIdorsia Ltd | +0.25 | +2.25% |
OASMYVivesto AB | 0.00 | 0.00% |
Next reporting date | May 4, 2023 |
EPS forecast (this quarter) | -$3.50 |
Annual revenue (last year) | $1.4B |
Annual profit (last year) | -$2.0B |
Net profit margin | -141.52% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters George Town, George Town |